Ivan Gudz

Rivaroxaban in Peripheral Artery Disease after Revascularization

Marc P. Bonaca, Rupert Bauersachs, Sonia S. Anand et al. · New England Journal of Medicine · 2020 · 980 citations · Full text

Medicine, Pharmacotherapy, Surgery +15

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial

Gary E. Raskob, Nick van Es, Annelise Segers et al. · The Lancet Haematology · 2016 · 155 citations

Medicine, Oncology, Pharmacotherapy +13

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

Rupert Bauersachs, Michael Szarek, Marianne Brodmann et al. · Journal of the American College of Cardiology · 2021 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies

G. Ralph Corey, Jeffery S. Loutit, Greg Moeck et al. · Antimicrobial Agents and Chemotherapy · 2018 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits

Nicholas Govsyeyev, Mark R. Nehler, Michael S. Conte et al. · Journal of Vascular Surgery · 2022 · 19 citations · Full text

Medicine, Perioperative Medicine, Surgery +14